These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 28343538

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
    Dong J, Yang Y, Han D, Zhao Q, Liu C, Sun H, Wang Z, Lin H, Huang W.
    Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dosimetric Comparison of Sequential Versus Simultaneous-integrated Boost in Early-stage Breast Cancer Patients Treated With Breast-conserving Surgery.
    Onal C, Efe E, Guler OC, Yildirim BA.
    In Vivo; 2019; 33(6):2181-2189. PubMed ID: 31662554
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Small-arc volumetric-modulated arc therapy: A new approach that is superior to fixed-field IMRT in optimizing dosimetric and treatment-relevant parameters for patients undergoing whole-breast irradiation following breast-conserving surgery.
    Yu J, Hu T, Chen Y.
    Medicine (Baltimore); 2016 Aug; 95(34):e4609. PubMed ID: 27559956
    [Abstract] [Full Text] [Related]

  • 9. An accelerated hypofractionated schedule with a daily concomitant boost after breast conservation surgery: the feasibility and toxicity.
    Ghannam AA, Khedr RA.
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):39-44. PubMed ID: 26833225
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature.
    De Rose F, Fogliata A, Franceschini D, Iftode C, Navarria P, Comito T, Franzese C, Fernandes B, Masci G, Torrisi R, Tinterri C, Testori A, Santoro A, Scorsetti M.
    Breast; 2018 Dec; 42():31-37. PubMed ID: 30149235
    [Abstract] [Full Text] [Related]

  • 12. Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis.
    De Rose F, Fogliata A, Franceschini D, Iftode C, D'Agostino GR, Comito T, Franzese C, Di Brina L, Clerici E, Loi M, Navarria P, Gatzemeier W, Testori A, Tinterri C, Lobefalo F, Tomatis S, Cozzi L, Scorsetti M.
    Clin Breast Cancer; 2020 Dec; 20(6):527-533. PubMed ID: 32665192
    [Abstract] [Full Text] [Related]

  • 13. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
    Liem X, Chira C, Fourquet A, Campana F, Peurien D, Fournier-Bidoz N, Kirova YM.
    Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results.
    De Rose F, Fogliata A, Franceschini D, Navarria P, Villa E, Iftode C, D'Agostino G, Cozzi L, Lobefalo F, Mancosu P, Tomatis S, Scorsetti M.
    Radiat Oncol; 2016 Sep 17; 11(1):120. PubMed ID: 27639373
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intensity-modulated radiotherapy and hypofractionated volumetric modulated arc therapy for elderly patients with breast cancer: comparison of acute and late toxicities.
    Fiorentino A, Gregucci F, Mazzola R, Figlia V, Ricchetti F, Sicignano G, Giajlevra N, Ruggieri R, Fersino S, Naccarato S, Massocco A, Corradini S, Alongi F.
    Radiol Med; 2019 Apr 17; 124(4):309-314. PubMed ID: 30547358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.